Author Archives: Gastroenterology Journal

Mentoring disparities in gastroenterology: the path forward

Posted in News | Comments Off on Mentoring disparities in gastroenterology: the path forward

Protective Role of Spermidine in Colitis and Colon Carcinogenesis

Because inflammatory bowel disease is increasing worldwide and can lead to colitis-associated carcinoma (CAC), new interventions are needed. We have shown that spermine oxidase (SMOX), which generates spermidine (Spd), regulates colitis. Here we determ… Continue reading

Posted in News | Comments Off on Protective Role of Spermidine in Colitis and Colon Carcinogenesis

Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)

Functional cure, defined by hepatitis B surface antigen (HBsAg) loss, is rare during nucleos(t)ide analogue (NA) therapy and guidelines on finite NA therapy have not been well established. We aim to analyze off-therapy outcomes following NA cessation i… Continue reading

Posted in News | Comments Off on Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)

COVID-19 Vaccination Is Associated with Reduced SARS CoV2 Infection and Death in Liver Transplant Recipients

Posted in News | Comments Off on COVID-19 Vaccination Is Associated with Reduced SARS CoV2 Infection and Death in Liver Transplant Recipients

Donor screening for fecal microbiota transplantation in China: Evaluation of 8,483 candidates

Posted in News | Comments Off on Donor screening for fecal microbiota transplantation in China: Evaluation of 8,483 candidates

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients with Crohn’s Disease

Mirikizumab is a humanized monoclonal antibody targeting IL-23p19 with demonstrated efficacy in psoriasis and ulcerative colitis. We investigated the safety and efficacy of mirikizumab in patients with moderate-to-severe Crohn’s disease (CD). Continue reading

Posted in News | Comments Off on Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients with Crohn’s Disease

Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse

Posted in News | Comments Off on Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse

How We Approach Difficult to Eradicate Helicobacter pylori

Gastroenterologists spend much of their working lives focused on cancer prevention through an array of approaches, including screening and surveillance colonoscopy, endoscopic surveillance of Barrett’s esophagus, investigating pancreatic cysts noted in… Continue reading

Posted in News | Comments Off on How We Approach Difficult to Eradicate Helicobacter pylori

Advancing Diversity, Equity, and Inclusion in Scientific Publishing

Inequities in multiple dimensions are pervasive across groups and intersections of race, sex, sexual orientation, gender identity, geography, and others stratifications in society.1–7 The disproportionate effect of COVID-19 on racial and ethnic minorit… Continue reading

Posted in News | Comments Off on Advancing Diversity, Equity, and Inclusion in Scientific Publishing

The “Itis” in Chronic Radiation Proctitis is alrightis but RAVE is too superficial a shave.

Posted in News | Comments Off on The “Itis” in Chronic Radiation Proctitis is alrightis but RAVE is too superficial a shave.